Strategy & Business Cases

Strategic Case Planning

Developing a strategy establishes the right direction for your organisation and its partners/stakeholders, and helps everyone focus their efforts on getting there.

Sapere provides an objective view of complex issues, providing analytical and other support to make better choices about where, when and how to invest effort and resources.

Our consultants are experienced in the development of Better Business Cases, providing objective analysis in a consistent format to decision-makers.

This allows for better comparability and transparency and enables the government to make smart investment decisions that maximise public value.

What we do

Developing good strategy

Analysis of business goals and objectives, to align current practice and performance SWOT and PEST(LE) analysis
Environmental scans and evidence reviews
Develop and application of prioritisation frameworks
Proactive engagement of stakeholders to consider their needs, wants, expertise, stake in the organisation and desired outcomes
Develop outcome and monitoring frameworks.

Investment proposals

Facilitate Investment Logic Mapping, to develop and document the logic underpinning a potential investment
Undertake economic appraisal of potential investment options, using quantitative methods and qualitative methods such as multi-criteria and cost-benefit analysis
Develop financial models to demonstrate the financial impact of investment proposals
Benefits management planning and modelling.

Examples of our work in strategy and business cases

New Dunedin Hospital detailed business cases

We provide clients with a sound evidential basis to support decision-making in a variety of contexts, conducting sophisticated analysis and modelling support.

Key contacts

David Moore

Managing Director
WELLINGTON
dmoore@thinkSapere.com

David Graham

Managing Director
MELBOURNE
dgraham@thinkSapere.com

Matt Balmford

Director
MELBOURNE
mbalmford@thinkSapere.com

Dr Richard Tooth

Director
SYDNEY
rtooth@thinkSapere.com

Some of our recent articles of interest

The economic benefits of a circular economy in Auckland

Client: Sustainable Business Network

This report provides a view on the potential economic benefits of a more circular economy for Auckland. It has been commissioned by the Sustainable Business Network to inform its report on the circular economy opportunity for Auckland.

The emissions footprint of broadband in New Zealand

Client: Chorus

This paper provides a first assessment of the emissions footprint of the current New Zealand fibre network, with a focus on internet provision to households and small to medium-sized businesses.

Making New Zealand safer: regulating the engineering profession

Client: Ministry of Business, Innovation, and Employment

Sapere prepared a Regulatory Impact Statement (RIS) and cost-benefit analysis (CBA) to support MBIE’s proposal for an occupational regulatory regime for engineers.

Infrastructure consenting for climate targets

Client: Te Waihanga / New Zealand Infrastructure Commission

This research models the impact on New Zealand’s emissions reduction targets if the current resource consenting system continues to delay decisions on infrastructure project consenting.

Māori Primary Health Care

Client: Wai 2575 Claimants

Sapere were asked by the claimants to respond to the Waitangi Tribunal’s recommendation that a methodology be developed to measure the degree of underfunding of Māori PHOs and providers.

Sizing of the backyard and micro-commercial egg production in Australia

Client: Australian Eggs

Which came first the chicken or the egg? We don’t have the answer to that, but we do know the size of backyard and micro-commercial egg production in Australia.

A chance to make clinical trials sustainable, effective, and equitable in Aotearoa New Zealand

Client: Liggins Institute University of Auckland

Sapere provided extensive analytical support to a consortium of researchers from the University of Auckland and the University of Otago on a Health Research Council (HRC) and Ministry of Health funded research project. The consortium was brought together to review Aotearoa New Zealand’s clinical trials activity and infrastructure.